Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
FibrosIX
company
About
FibrosIX is a biotechnology company develops drugs to prevent lung fibrosis in cancer patients.
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $256K
- Industries
- Biotechnology,Health Care,Medical
- Founded date
- Jan 1, 2016
- Operating Status
- Active
FibrosIX is a biotechnology company develops drugs to prevent lung fibrosis in cancer patients. The company was founded in 2016 and is headquartered in East Lansing, Michigan.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$256K
FibrosIX has raised a total of
$256K
in funding over 2 rounds. Their latest funding was raised on
Feb 18, 2021 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Feb 18, 2021 | Grant | $256K | 1 |
National Science Foundation
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
FibrosIX is funded by 1 investors.
National Science Foundation
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
National Science Foundation
|
Yes | Grant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
